| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,054,607 | 1,431,642 | 1,529,767 | 1,328,228 | | Cost of Revenue | 909,543 | 1,099,232 | 1,174,196 | 1,032,375 | | | Gross Profit | 145,064 | 332,410 | 355,571 | 295,853 | | | Operating Expenses | | Research Development | 17,095 | 17,120 | 17,323 | 18,563 | | Selling General and Administrative | 45,928 | 94,861 | 77,361 | 69,801 | | Non Recurring | 24,072 | 28 | (243) | 631 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 57,969 | 220,401 | 261,130 | 206,858 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 876 | 5,146 | 4,527 | (2,635) | | Earnings Before Interest And Taxes | 57,397 | 222,368 | 253,754 | 204,223 | | Interest Expense | 7,410 | 6,081 | 6,705 | 6,596 | | Income Before Tax | 49,987 | 216,287 | 247,049 | 197,627 | | Income Tax Expense | 6,999 | 67,049 | 78,954 | 55,844 | | Minority Interest | (1,448) | (3,179) | (11,903) |
-
| | | | Net Income From Continuing Ops | 42,988 | 149,238 | 168,095 | 141,783 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,988 | 149,238 | 168,095 | 141,783 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $42,988 | $149,238 | $168,095 | $141,783 |
|
0.45% Nasdaq 
0.20%
Income Statement
